Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Oct;9(4):733-9.
doi: 10.1111/j.1750-3639.1999.tb00554.x.

Transgenic models of tauopathies and synucleinopathies

J Q Trojanowski  1 , V M Lee
Affiliations
Review

Transgenic models of tauopathies and synucleinopathies

J Q Trojanowski et al. Brain Pathol. 1999 Oct.

Abstract

Rapidly emerging concepts about the pathobiology and defining phenotypes of two major classes of neurodegenerative disease known as tauopathies and synucleinopathies are bringing these diseases into shaper focus. Significantly, recent research has substantially advanced understanding of these neurodegenerative disorders thereby providing fresh opportunities for the development of transgenic (TG) mouse models. Since the availability of such animal models will accelerate efforts to discover more effective therapies, we review the current status of efforts to generate informative TG mouse models for tauopathies and synucleinopathies and other neurodegenerative disorders characterized by prominent filamentous brain lesions.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Baba M, Nakajo S, Tu P‐H, Tomita T, Nakaya K, Lee VM‐Y, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α‐synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879–884. - PMC - PubMed
    1. Brion J‐P, Tremp G, Octave J‐N (1999) Transgenic expression of the shortest human tau affects its compartmental‐ization and its phosphorylation as in the pre‐tangle stage of Alzheimer's disease. Am J Pathol 154: 255–270. - PMC - PubMed
    1. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM‐Y, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998) Pathogenic implications of mutations in the tau gene in pallido‐ponto‐nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 95: 13103–13107. - PMC - PubMed
    1. D'Souza I, Poorkaj P, Hong M, Nochlin D, Lee VM‐Y, Bird TD, Schellenberg GD (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism‐chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc Natl Acad Sci USA 96: 5598–55603. - PMC - PubMed
    1. Dumanchin C, Camuzal A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier‐Veber P, Martin C, Penet C, Charbonnier F, Agid Y, Brice A (1998) Segregation of a missense mutation in the microtubule‐associated protein tau with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 7: 1825–1829. - PubMed

Publication types

LinkOut - more resources